<DOC>
	<DOCNO>NCT01126697</DOCNO>
	<brief_summary>The study include 120 participant age 8 Duchenne , Becker , autosomal recessive limb-girdle ( specifically : LGMD 2C-2F 2I ) muscular dystrophy clinical cardiac symptom . Participants randomize one four arm : Arm 1 CoQ10 alone , Arm 2 Lisinopril alone , Arm 3 CoQ10 Lisinopril Arm 4 No study medication . Randomization stratify ambulatory status corticosteroid use . The primary outcome study myocardial performance index ( MPI ) , measure standard Doppler echocardiography . The study last 24 month visit Months 0.5,1.5 , 6 , 12 , 18 24 . Following completion Clinical Trial Coenzyme Q10 Lisinopril , participant offer participation companion protocol : PITT1215 A Natural History Companion Study PITT0908 : Clinical Trial Coenzyme Q10 Lisinopril Muscular Dystrophies . The objective study evaluate longitudinal natural history DMD , BMD , LGMD2I evaluate effect Coenzyme Q10 and/or Lisinopril prevention cardiac dysfunction disorders.This 18-month longitudinal natural history study design accompany Clinical Trial Coenzyme Q10 Lisinopril Muscular Dystrophies .</brief_summary>
	<brief_title>Clinical Trial Coenzyme Q10 Lisinopril Muscular Dystrophies</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<mesh_term>Muscular Dystrophies , Limb-Girdle</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>8 year age old Confirmed genetic diagnosis Duchenne , Becker , Limb Girdle muscular dystrophy Betablocker naïve Screening Doppler echocardiographic MPI measurement great equal 0.40 high MPI value ( spectral tissue ) circumferential strain measure STE less negative equal 23 Normal leave ventricular fractional shortening ( ≥28 % ) clinical cardiac symptom Has participate therapeutic research protocol within last 6 month prior screen Ability swallow tablet Spine curvature great 30 % ( base xray perform screen ) History significant concomitant illness significant impairment renal hepatic function History hypersensitivity ACE inhibitor History idiopathic hereditary angioedema history angioedema prior ACE inhibitor use Use carnitine , creatine , glutamine , herbal medicine ( would include herbal teas unless consume daily intend medicinal effect ) 3months prior enrollment CoQ10 and/or ACE inhibitor use duration great 6 month CoQ10 and/or ACE inhibitor use 3months prior enrollment CoQ10 serum level 2.5 ug/ml high Investigator assessment inability comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Cardiac</keyword>
	<keyword>Muscular Dystrophy</keyword>
	<keyword>Randomized</keyword>
</DOC>